Log In
BCIQ
Print this Print this
 

amphetamine (Adzenys XR-ODT) (NT-0202)

Also known as: NT0202

  Manage Alerts
Collapse Summary General Information
Company Neos Therapeutics Inc.
DescriptionExtended-release, orally disintegrating tablet formulation of amphetamine polistirex using Neos' Rapidly Disintegrating Ionic Masking (RDIM) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation
PartnerShire plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/09/2014

Undisclosed

0

0

Get a free BioCentury trial today